UniCredit Knock-Out AMD 13.11.202.../ DE000HD69QP3 /
2024-10-04 8:17:33 PM | Chg.-0.55 | Bid10:00:32 PM | Ask10:00:32 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
8.21EUR | -6.28% | - Bid Size: - |
- Ask Size: - |
ADVANCED MIC.DEV. D... | - - | 2024-11-13 | Call |
GlobeNewswire
09-01
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
08-27
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
08-27
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
08-26
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
08-23
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...
GlobeNewswire
08-21
AMD 2023-24 Corporate Responsibility Report: Advancing Sustainability, Collaboration and Inclusion
GlobeNewswire
08-20
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facil...
GlobeNewswire
08-20
Gamescom 2024 - HP Elevates the Gaming World through Customizable Solutions for a Personalized Playe...
GlobeNewswire
08-19
AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solut...
GlobeNewswire
08-16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
08-14
Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corp...